logo
  

U.S. Consumer Sentiment Slumps Slightly More Than Initially Estimated In June

consumer sentiment 062422 lt

Consumer sentiment in the U.S. tumbled by slightly more than initially estimated in the month of June, revised data from the University of Michigan revealed on Friday.

The report showed the consumer sentiment index for June was downwardly revised to 50.0 from the preliminary reading of 50.2.

The consumer sentiment index is down sharply from the final May reading of 58.4, plunging to its lowest level on record.

The steep drop by the headline index came as the current economic conditions index plunged to 53.8 in June from 53.3 in May, while the index of consumer expectations tumbled to 47.5 from 55.2.

"Consumers across income, age, education, geographic region, political affiliation, stockholding and homeownership status all posted large declines," said Surveys of Consumers Director Joanne Hsu. "About 79% of consumers expected bad times in the year ahead for business conditions, the highest since 2009."

She added, "Inflation continued to be of paramount concern to consumers; 47% of consumers blamed inflation for eroding their living standards, just one point shy of the all-time high last reached during the Great Recession."

The report showed one-year inflation expectations were unchanged at 5.3 percent, while five-year inflation expectations inched up to 3.1 percent in June from 3.0 percent in May.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
While reporting financial results for the first quarter on Wednesday, medical devices company Boston Scientific Corp. (BSX) raised its adjusted earnings and net sales growth guidance for the full-year 2024. For fiscal 2024, the company now projects earnings in a range of $1.43 to $1.48 per share and... Shares of Roche Holding AG were losing around 3 percent in Switzerland after the drug major reported weak sales in its first quarter and confirmed fiscal 2024 outlook. Excluding COVID-19-related products, quarterly sales increasedy 7 percent. For fiscal 2024, Roche continues to expect an increase in group sales in the mid single digit range at constant exchange rates. Dr. Reddy's Laboratories Ltd. is recalling six lots of Sapropterin Dihydrochloride Powder for Oral Solution 100 mg to the consumer level. According to the U.S. Food and Drug Administration, the recall was due to powder discoloration in some packets leading to decreased potency.

This week, we feature Nigeria’s combat with meningitis, Hostile takeover bid for Vanda Pharma, US opioid crisis, Sammy’s Milk’s safety concerns, and X4’s Mavorixafor’s fast-track status.

View More Videos
Follow RTT